📰 Sequella Inc News
Sequella Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sequella Inc. Real-time updates on events, politics, business and more.
May 28, 2024
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The
May 18, 2024
For File 2008 Contact: Jim Sliwa jsliwa@asmusa.org 202-942-9297 American Society for Microbiology Research urgently needed to evaluate potential risks to humans People with Crohn's disease (CD) are seven-fold more likely to have in their gut tissues the bacterium that causes a digestive-tract disease in cattle called Johne's disease. The role this bacterium may or may…
November 20, 2023
The global landscape of ocular health is poised for a significant transformation as the Global Ocular Tuberculosis Therapeutics Industry is anticipated to surge to a noteworthy US$753.2 million by 2032. This projection, marking a substantial increase from US$405.0 million in 2022, is underscored by a robust Compound...
July 19, 2023
The global ocular tuberculosis therapeutics market is expected to be worth $753.2 million by 2032, up from $405.0 million in 2022, and to grow at a 5.8% CAGR during the forecast period.Ocular Tuberculosis Therapeutics Market: OverviewThere are different mechanisms through which ocular tuberculosis may occur, involvi...
July 3, 2023
[Report of 333 Pages] The global ocular tuberculosis therapeutics market is expected to be worth $753.2 million by 2032, up from $405.0 million in 2022, and to grow at a 5.8% CAGR during the forecast period.Ocular Tuberculosis Therapeutics Market: OverviewThere are different mechanisms through which ocular tuberculo...
March 6, 2023
In the last 15 years, Romita Ghosh, a scientist by training and an entrepreneur by passion, has co-founded and successfully sustained four companies. She built them from scratch, developing ideas into products and services that touch peoples ...
April 13, 2022
The "Pulmonary Tuberculosis Global Clinical Trials Review, 2022" clinical trials has been added to ResearchAndMarkets.com's offering. This clinical trial report provides an overview of Pulmonary Tuberculosis
April 13, 2022
DUBLIN--(BUSINESS WIRE)--The "Pulmonary Tuberculosis - Global Clinical Trials Review, 2022" clinical trials has been added to ResearchAndMarkets.com's offering. This clinical trial report provides an overview of Pulmonary Tuberculosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Pulmonary Tuberculosis. Report includes an overview of…